Outdoor pot growing will further commodify cannabis, Canaccord Genuity says

In a move that will have implications for Canada’s nascent marijuana industry, this week the federal government is expected to announce new regulations for the production of legalized cannabis which will allow outdoor pot growing by companies. The move will likely put pricing pressure on growers and further the commodification of cannabis, says analyst Neil Maruoka of investment bankers Canaccord Genuity.

Up until now, regulations for growing medical use cannabis — and, come the October 17 start date, for the production of recreational use bud — have required that licensed producers grow in greenhouses or other indoor facilities. But the new rules will allow for outdoor cultivation.

“Our decision to allow outdoor grow under strict rules is the result of extensive consultations and will contribute to creating a diverse and competitive legal cannabis industry with the ultimate goal of displacing the illegal market,” said Thierry Bélair, a spokesman for Health Minister Ginette Petitpas Taylor.

That stipulation has been campaigned against by industry representatives, including the Cannabis Canada Council, which has stated that outdoor growing will hinder the government’s stated aim of taking cannabis out of the black market.

Last month, Cannabis Canada Council executive director Allan Rewak told a Senate standing committee that along with increasing the likelihood of theft, outdoor growing will impact the quality of cannabis crops and potentially lead to “cross pollination and contamination.” Rewak said that he’s also concerned about “the danger of unintentional exposure to agricultural pesticides.’

Allowing outdoor cultivation will also put downward pressure on a legalized market that was already headed towards cash crop status, says Maruoka.

“Although several greenhouse producers in Canada have already achieved <$1.00 per gram cash costs, the inclusion of outdoor grow in Canada could see production costs decline substantially lower,” says Maruoka in an industry update on Tuesday. “Although a lower cost base could help pad margins in the short-term, we believe the addition of outdoor grow in Canada is more likely to expedite commoditization of the flower and could put substantial pressure on pricing.”

Maruoka says that even with the October start date decided, there are still a number of issues to work out and that the rec cannabis roll-out is likely to be bumpy at first, considering the challenges for cultivation and distribution that lie ahead.

“Although logistical hurdles remain, we believe positive industry catalysts are still on the horizon,” he says. “This includes major provinces such as Ontario, Alberta and BC still to announce initial tender allotments for product and the legislation of more recreational friendly products, such as vape pens, edibles and other derivative cannabis products that will become increasingly important for producers as the cultivation of cannabis is expected to become largely commoditized.”

More Cantech Cannabis

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago